Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
52.96
-0.27 (-0.51%)
At close: Oct 24, 2025, 4:00 PM EDT
53.09
+0.13 (0.25%)
After-hours: Oct 24, 2025, 7:32 PM EDT
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Jun 30, 2025 | 21.87B | 327.04M |
| Mar 31, 2025 | 20.94B | 83.31M |
| Dec 31, 2024 | 19.85B | 96.37M |
| Sep 30, 2024 | 18.30B | 102.74M |
| Jun 30, 2024 | 17.25B | 78.34M |
| Mar 31, 2024 | 16.58B | 425.12M |
| Dec 31, 2023 | 15.49B | 458.69M |
| Sep 30, 2023 | 14.08B | 360.46M |
| Jun 30, 2023 | 12.75B | 645.53M |
| Mar 31, 2023 | 11.69B | 853.34M |
| Dec 31, 2022 | 10.48B | 1.15B |
| Sep 30, 2022 | 9.68B | 1.41B |
| Jun 30, 2022 | 8.89B | 1.44B |
| Mar 31, 2022 | 8.31B | 1.46B |
| Dec 31, 2021 | 7.70B | 1.42B |
| Sep 30, 2021 | 7.27B | 1.46B |
| Jun 30, 2021 | 6.76B | 1.60B |
| Mar 31, 2021 | 6.65B | 1.56B |
| Dec 31, 2020 | 6.80B | 1.61B |
| Sep 30, 2020 | 6.78B | 1.74B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.